Home Page
18:32:33 EDT Mon 28 Jul 2014
Enter Symbol
or Name
USA
CA



MOMENTA PHARMACEUTICALS INC
Symbol U : MNTA
Recent Sedar Documents

Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST

2012-11-27 16:30 ET - News Release

CAMBRIDGE, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the Deutsche Bank 2012 dbAccess BioFEST will be webcast on Tuesday, December 4 at 1:05 p.m. ET.

The audio webcast of the presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

CONTACT: Lora Pike
         Momenta Pharmaceuticals, Inc.
         ir@momentapharma.com
         617.395.5189

© 2014 Canjex Publishing Ltd. All rights reserved.